+91-8668442535

Automated External Defibrillators Market By Defibrillator (Semi-Automated External Defibrillators, Fully Automated External Defibrillators) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025

Automated external defibrillators (AEDs) are portable and lightweight electronic devices that deliver electric shocks to the heart through the chest. AEDs diagnose cardiac arrhythmias and ventricular tachycardias and use defibrillation to restore normal rhythm.AEDs are critical in the treatment of SCA, which is caused by ventricular fibrillation and ventricular tachycardia. According to the American Heart Association (AHA), SCA is a leading cause of death globally, accounting for more than 350,000 medical emergencies every year in the U.S. alone. Factors such as growing government initiatives regarding public access defibrillator (PAD) programs, leading to the setup of defibrillators in populated public places, would drive the demand for automated external defibrillators. The growing prevalence of cardiac diseases, an aging population, and technological advancements in defibrillator technologies will drive the automated external defibrillator market even further.

The aforementioned report, titled "Automated External Defibrillators Market: Growth, Future Prospects, and Competitive Analysis, 2017–2025," delivers competitive market insights for the overall automated external defibrillators industry. This report version proposes to present the size and forecast of the global market for automated external defibrillators for the period of 2015–2015, with a forecast duration of 2017–2025. The market is segmented in terms of defibrillator type, different geographies, and country analysis.

In terms of product types, the market is categorized into semi-automated external defibrillators and fully automatic external defibrillators. On the basis of geographical segmentation, the market was studied across North America (Canada and the U.S.), Europe (Germany, the U.K., and the rest of Europe), Asia Pacific (Japan, China, and the rest of Asia Pacific), Latin America (Mexico, Brazil, and the rest of Latin America), and the Middle East and Africa (the GCC and the rest of the Middle East and Africa). Market estimation for each region and country is analyzed for the focus period of 2015–2025, with forecasts from 2017–2025 considering 2016 as the base year.

To study the market competition scenario, a market positioning and company profile analysis of leading players operating in the global automated external defibrillators market has been provided in the report. The parameters considered for mapping the leading companies were based on business overview, financial analysis, product portfolio, and key developments in the company pertaining to the industry of automated external defibrillators.

A qualitative assessment of the market was done by monitoring the market drivers, market restraints, and market opportunities to get a hold of current market dynamics and determine the future trend of the automated external defibrillators market. The report also comprises an analysis in terms of the most attractive investment proposition for regional markets and business strategies undertaken by companies, such as mergers, acquisitions, and major collaborations, to deliver a competitive landscape of the players in the market that would help decision-makers in the automated external defibrillators market.

Thus, the aforementioned study provides a comprehensive view of market trends and future opportunities in the global market for automated external defibrillators. The major players operating in the market include Boston Scientific, Nihon Kohden Corporation, Philips Healthcare, Zoll Medical, Biotronik, GE Healthcare, St. Jude Medical, Mindray Medical International Limited, Schiller AG, and others.

Based on the type of defibrillator, the market for automated external defibrillators is segmented into:

  • Semi-Automated External Defibrillators
  • Fully Automated External Defibrillators

The portability and easy-to-use nature of AEDs make it possible for nonmedical users to respond to a medical emergency where defibrillation is required. AEDs analyze irregular heartbeats and prompt the delivery of shock when required. Fully automated external defibrillators deliver the shock automatically, analyzing the cardiac rhythm. Rising cases of cardiac diseases globally and the launch of technologically advanced defibrillators are the prime drivers for the growth of the automated external defibrillators market. Moreover, growing government initiatives across North America and Europe for the establishment of public access defibrillator (PAD) programs would additionally drive the automated external defibrillator market. AEDs, on the other hand, can only treat ventricular fibrillation and ventricular tachycardia and cannot treat other types of cardiac arrhythmia.AEDs also take significantly longer to detect cardiac rhythm abnormalities than manual units, which is a disadvantage of the automated external defibrillator market.

For the purpose of this study, the global automated external defibrillators market is categorized as follows:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Italy
    • U.K.
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • India
    • China
    • Japan
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East and Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

In the year 2016, North America held the largest share in the global automated external defibrillators market due to growing cases of cardiac diseases in the region. Heart diseases are the leading cause of death in the U.S., with more than 610,000 people succumbing to death every year. According to the Centers for Disease Control and Prevention (CDC), atrial fibrillation is the most common type of heart arrhythmia, affecting approximately 2.7 to 6.1 million people in the U.S. in 2015, a number that is said to increase due to the rising geriatric population in the country. Moreover, the growing government focus on public access defibrillator (PAD) initiatives in the region would further drive the market during the forecast period. Asia Pacific emerged as the fastest-growing regional segment in the global automated external defibrillators market due to technologically advanced defibrillators entering the Asia Pacific market, the growing prevalence of target diseases, and the rise in the geriatric population, which fuel the market's growth in Asia Pacific.

Frequently Asked Question:

The market for Automated External Defibrillators Market is expected to reach USD$ XX Bn in 2025.

The Automated External Defibrillators Market is expected to see significant CAGR growth over the coming years, at 7.2%.

The report is forecasted from 2017 -2025.

The base year of this report is 2016.

Boston Scientific, Nihon Kohden Corporation, Philips Healthcare, Zoll Medical, Biotronik, GE Healthcare, St. Jude Medical. are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Dec 2017
Category:  Medical Devices
Report ID:   58909
Report Format:   PDF
Pages:   120
Rating:    4.4 (65)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support